American presidents throughout history have broken with precedent before, but for a president-elect to launch a crypto “meme coin” days before his inauguration is really out there on the ...

The random cutaway gags from Family Guy translate well to memes, and one of the most popular jokes is a scene featuring Peter telling his family that he “did not care for The Godfather.” ...

The co-founder of Vine announced this week that he is launching a meme coin named after the now-defunct short-form video app. Rus Yusupov, who co-founded the app with Dom Hofmann and Colin Kroll ...

The $VINE meme coin, launched by Vine co-founder Rus Yusupov, surged in value following Elon Musk's hint at a Vine comeback. The coin's market cap reached $400 ...

One in eight adults in the U.S. has taken Ozempic or another type of GLP-1 drug, surveys show — and now a major new study has revealed a long list of benefits and some little-known risks.

Few drugs have captured public attention like Ozempic; many of us have even taken it. The type 2 diabetes medication, generically known as semaglutide, has received unprecedented attention in the ...

US President Donald Trump has been criticised for launching a meme-coin while saying he "doesn't know much" about the cryptocurrency. The digital coin called TRUMP appeared on his social media ...

In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond weight loss. Published in the journal Nature Medicine, this new study ...

Oprah Winfrey said taking weight-loss drugs, like Ozempic and Wegovy, helped her realize the truth about 'thin people.' In 2023, the media mogul, 70, finally admitted to using an undisclosed GLP-1 ...

Most people know that GLP-1 receptor agonist medications like Ozempic and Wegovy can cause relatively minor side effects like nausea and diarrhea. But new research confirms that more serious ...

Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much as 22%. Novo Nordisk said a Phase 1b/2a clinical trial of amycretin ...